The biotech industry produced COVID-19 vaccines and treatments in record time – earning the global spotlight as science helped the world get back on track. But pandemic or not, biotech innovators work every day on science-driven miracles to cure disease, combat climate change, and feed our growing world.
Bio.News is a daily news website exploring the wonders of biotechnology and the intersection of biotech innovation and U.S. and international policy.
Our independent journalists from around the world tell the story of this fast-paced industry and how federal, state, and international policy and regulations can support – or thwart – biotech innovation and investment.
We also feature analysis from the world’s top scientists and biotech CEOs to explore how we can drive the biorevolution.
Produced by BIO
Bio.News is a production of the Biotechnology Innovation Organization (BIO). BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers, and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial, and environmental biotechnology products.
A collaboration between scientists, biotech industry leaders, and independent journalists, Bio.News is a voice of science and for science – driving BIO’s Seven Core Strategic Priorities with powerful storytelling and providing a platform for news and information about BIO members and the patients and stakeholders they serve.
Learn more about BIO at www.bio.org.
Bio.News is edited by Theresa Brady, Samantha Sault, and Tom Popper, with support from independent writers and editors worldwide.